IgA nephropathy Life with Disease

Prognosis: Understanding Your Journey Ahead

When you receive a diagnosis of IgA nephropathy, one of the first questions that comes to mind is naturally about what lies ahead. The course of this disease varies widely from person to person, which makes it difficult to predict exactly how it will affect any individual. Some people may live with the condition for decades with minimal symptoms and stable kidney function, while others experience a more rapid decline in kidney health.1

Research shows that approximately 20 to 40 percent of people with IgA nephropathy may develop chronic kidney disease or progress to kidney failure within 20 years of their diagnosis.12 However, this statistic should be understood in context: it means that the majority of patients do not progress to kidney failure. Many people maintain relatively stable kidney function for years or even decades, especially with proper management and treatment.

The disease often progresses slowly, measured not in months but in years. For some individuals, particularly those diagnosed early and without significant protein loss in their urine, the prognosis can be quite favorable. Regular monitoring through blood and urine tests allows healthcare teams to track kidney function and make adjustments to treatment as needed.3

One of the most important factors affecting prognosis is the amount of protein being lost through the urine, a condition known as proteinuria. Higher levels of proteinuria generally indicate a more serious course of disease and a greater risk of progression. Blood pressure control is equally critical—keeping blood pressure well-managed can significantly slow the damage to kidneys over time.4

It's important to remember that advances in treatment options have improved outcomes for many patients. With newly approved medications specifically targeting IgA nephropathy, along with supportive measures to protect kidney function, there is genuine reason for hope. Every person's journey is unique, and working closely with your healthcare team gives you the best chance at maintaining quality of life.

Natural Progression: How the Disease Develops

IgA nephropathy develops when clumps of a protein called immunoglobulin A, or IgA, deposit in the tiny filtering units of the kidneys called glomeruli. These deposits trigger inflammation, which gradually damages the kidney's ability to filter waste products from the blood.5

In the early stages, many people don't notice any symptoms at all. The disease can remain silent for years, quietly causing microscopic amounts of blood to leak into the urine—something only detectable through laboratory tests. This is why IgA nephropathy is sometimes discovered by accident during routine medical checkups or screenings for other conditions.3

As time passes without treatment, the inflammation caused by IgA deposits can lead to scarring of the nephrons, which are the functional units of the kidney that contain the glomeruli. This scarring process is often gradual. The kidneys have remarkable reserve capacity, meaning they can continue functioning even when some nephrons are damaged. However, as more nephrons become scarred and stop working, the kidney's overall filtering capacity diminishes.5

Some individuals experience episodes where their urine becomes visibly discolored—often described as tea-colored or cola-colored—especially following an upper respiratory infection like a cold or sore throat. This happens because the infection triggers an immune response that increases IgA circulation in the body, leading more of these protein complexes to lodge in the kidneys. Between these episodes, the person may feel completely well.6

Without intervention, the ongoing damage can eventually lead to chronic kidney disease. The kidneys lose their ability to remove waste and excess fluid from the body effectively. As kidney function declines, waste products begin to build up in the bloodstream, potentially affecting other organ systems and leading to serious health consequences.7

The rate of progression varies tremendously. Some people maintain stable kidney function for many years, while others experience a more rapid decline. Factors that influence progression include the severity of proteinuria, blood pressure levels, the degree of kidney damage seen on biopsy, and individual genetic factors. This variability underscores the importance of regular monitoring and proactive management.

Possible Complications: What Can Go Wrong

As IgA nephropathy progresses, several complications can develop that affect not just the kidneys but your overall health and wellbeing. Understanding these potential complications helps you recognize warning signs early and work with your healthcare team to prevent or manage them effectively.

One of the most common complications is high blood pressure, also called hypertension. The kidneys play a vital role in regulating blood pressure by controlling fluid balance and producing hormones that affect blood vessels. When IgA nephropathy damages the kidneys, this regulatory system becomes impaired. Unfortunately, high blood pressure creates a harmful cycle—it further damages the kidneys, which in turn makes blood pressure control even more difficult.6

Another serious complication is the development of nephrotic syndrome, a condition where large amounts of protein leak into the urine. This protein loss can cause swelling in the legs, ankles, face, and around the eyes. The swelling happens because protein normally helps keep fluid in the bloodstream; when protein levels drop too low, fluid leaks into surrounding tissues. People with nephrotic syndrome may also experience foamy urine, weight gain from fluid retention, and fatigue.7

Some individuals may experience episodes of sudden, severe kidney problems called acute kidney injury. This can occur during episodes of visible blood in the urine, particularly after infections. While kidney function often recovers after these episodes, repeated acute injuries can contribute to long-term damage.7

As kidney function declines, waste products that would normally be filtered out begin to accumulate in the blood. This can lead to a range of complications including anemia—a condition where you don't have enough healthy red blood cells to carry oxygen throughout your body. Kidney disease-related anemia causes persistent tiredness, weakness, and difficulty concentrating.8

Problems with bone health can also develop as the kidneys lose their ability to maintain proper mineral balance. The kidneys normally activate vitamin D and regulate calcium and phosphorus levels. When this system fails, bones can become weak and brittle, a condition called secondary hyperparathyroidism or metabolic bone disease.8

Cardiovascular complications represent another major concern. People with kidney disease have a significantly higher risk of heart disease, heart attacks, and strokes. This increased risk comes from multiple factors including high blood pressure, inflammation, abnormal cholesterol levels, and fluid imbalances that strain the heart.6

The most serious complication is progression to complete kidney failure, also called end-stage renal disease. At this point, the kidneys can no longer filter waste and maintain fluid balance on their own. Without treatment through dialysis or kidney transplantation, kidney failure is life-threatening. While not everyone with IgA nephropathy reaches this stage, understanding this risk emphasizes the importance of early and ongoing management.5

Impact on Daily Life: Living with IgA Nephropathy

Living with IgA nephropathy affects many aspects of daily life, from physical activities to emotional wellbeing, work responsibilities, and social relationships. Understanding these impacts helps patients develop strategies to maintain quality of life while managing their condition.

On a physical level, fatigue is one of the most common challenges. Many people with IgA nephropathy report feeling unusually tired, even when they haven't engaged in strenuous activities. This exhaustion can stem from anemia, the buildup of waste products in the blood, or simply the energy your body expends dealing with chronic inflammation. This tiredness might make it harder to keep up with work demands, household responsibilities, or social activities that you once enjoyed.9

Dietary adjustments become a significant part of daily life for many patients. Managing sodium intake requires careful attention to food labels and restaurant meals. Many convenience foods and processed items that you might have eaten regularly before diagnosis may now be off-limits due to their high sodium content. Learning to prepare meals differently, finding salt substitutes, and navigating social dining situations requires planning and adjustment.1011

The need for regular medical appointments and monitoring can disrupt work schedules and personal plans. Blood tests, urine collections, appointments with nephrologists, and potentially other specialists mean taking time away from work or other commitments. Some people find the constant medical oversight reassuring, while others find it burdensome and anxiety-provoking.

Physical activities may need modification depending on your symptoms and overall health status. While regular exercise is generally beneficial and recommended for kidney health, some people experience swelling in their legs and feet that makes certain activities uncomfortable. Others might have joint pain or general weakness that limits their activity level. Finding the right balance—staying active without overexertion—becomes an important consideration.10

The emotional and mental health impact of living with a chronic disease cannot be underestimated. Many people experience anxiety about their prognosis, worry about becoming a burden to loved ones, or fear progression to dialysis or transplantation. The uncertainty inherent in IgA nephropathy—not knowing how quickly or slowly the disease will progress—can be particularly difficult to cope with. Depression is also common among people living with chronic kidney disease.8

Work life can be affected in multiple ways. Some people need to request accommodations like flexible scheduling for medical appointments or the ability to rest when fatigue becomes overwhelming. Others may find that cognitive effects from reduced kidney function—such as difficulty concentrating or remembering details—impact their job performance. For those in physically demanding occupations, symptoms like fatigue and swelling may make certain tasks more challenging.

Social relationships sometimes shift when living with IgA nephropathy. Friends and family members may not understand why you're tired so often or why you need to be careful about what you eat. Explaining dietary restrictions at social gatherings or declining invitations due to fatigue can create feelings of isolation. Some people report that friends drift away when they can't participate in activities as actively as before.

Financial concerns add another layer of stress. Even with insurance, medical costs for ongoing monitoring, medications, and specialist visits can be substantial. Some people face difficult decisions about whether to take newer, more expensive medications or worry about insurance coverage for treatments. The potential future need for dialysis or transplantation brings additional financial anxiety.

Despite these challenges, many people with IgA nephropathy find ways to adapt and thrive. Developing coping strategies—such as pacing activities, planning rest periods, joining support groups, and maintaining open communication with healthcare providers—can significantly improve quality of life. Making lifestyle changes gradually rather than all at once often feels more manageable and sustainable.9

Support for Family: Navigating Clinical Trials Together

Family members and loved ones play an essential role in supporting someone with IgA nephropathy, especially when it comes to exploring treatment options like clinical trials. Understanding what clinical trials involve and how to help your loved one navigate these opportunities can make a significant difference in their care journey.

Clinical trials are research studies that test new treatments or approaches to managing IgA nephropathy. These studies are crucial for advancing medical knowledge and developing better therapies. For patients with IgA nephropathy, clinical trials represent an opportunity to access cutting-edge treatments that may not yet be widely available. However, the decision to participate in a clinical trial can feel overwhelming, and this is where family support becomes invaluable.8

One of the most important ways family members can help is by listening without judgment as your loved one explores their options. The decision to join a clinical trial is deeply personal and involves weighing potential benefits against risks and uncertainties. Some patients feel hopeful about trying new treatments, while others feel anxious about being part of research. Creating space for these feelings and concerns helps your loved one process their thoughts and make the decision that feels right for them.

Families can assist in practical ways by helping research available clinical trials. Multiple resources exist for finding trials specific to IgA nephropathy. Looking through clinical trial registries together, reading about study requirements and procedures, and compiling questions to ask the research team can be helpful shared activities. Having another set of eyes and ears during this process ensures important details aren't missed.12

Understanding the basics of clinical trial participation helps families provide better support. Clinical trials typically involve more frequent monitoring and testing than standard care. This means more appointments, more travel to research centers, and more time commitment. Families can help by offering transportation, attending appointments together, helping track symptoms or medication schedules, and providing emotional support during the additional medical visits.

It's important for family members to understand that participating in a clinical trial doesn't mean giving up standard care. Clinical trials for IgA nephropathy are designed with patient safety as the top priority. Patients continue to receive comprehensive medical care and are monitored closely throughout the study. If at any point a patient decides the trial isn't right for them, they can withdraw without affecting their regular medical care.8

Family members should also be aware that not everyone is eligible for every clinical trial. Studies have specific criteria regarding disease stage, current medications, other health conditions, and various other factors. If your loved one doesn't qualify for a particular trial, this doesn't reflect negatively on their condition or their ability to get good care—it simply means that particular study isn't the right match. Being prepared for this possibility helps manage expectations.

Financial considerations around clinical trials are another area where families can offer support. While many clinical trial expenses are covered by the study sponsor, there may be costs related to travel, time off work, or uncovered medical expenses. Discussing these practical matters openly and planning how to manage them reduces stress and helps make informed decisions about participation.

Helping your loved one prepare questions for the research team is another valuable contribution. Important questions might include: What is the purpose of this study? What treatments or procedures are involved? What are the potential risks and benefits? How long will the study last? What happens after the study ends? How will participation affect daily life? Writing these questions down together and ensuring they get answered helps everyone feel more confident about the decision.

Emotional support throughout the clinical trial process cannot be overstated. Some participants feel anxious about whether they're receiving the experimental treatment or a placebo in studies that use them. Others worry about side effects or whether the treatment is working. Family members can provide reassurance, celebrate small victories, and help navigate disappointments if results aren't what was hoped for.

Finally, families should remember to take care of themselves too. Supporting someone with a chronic illness is demanding, and caregivers often neglect their own physical and emotional needs. Seeking support for yourself—whether through friends, support groups for caregivers, or counseling—ensures you can provide sustained, effective support to your loved one.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

• TARPEYO (budesonide delayed release capsules) – A targeted-release corticosteroid taken once daily by mouth that helps lower the amount of protein in the urine for adults with high proteinuria levels whose disease is likely to progress quickly
• FILSPARI (sparsentan) – A dual angiotensin II and endothelin-1 receptor antagonist taken once daily by mouth to reduce proteinuria in adults with IgA nephropathy at risk of rapid disease progression
• Vanrafia (atrasentan) – An endothelin-1 receptor antagonist approved to reduce proteinuria in adults with IgA nephropathy at risk of rapid progression
• Fabhalta (iptacopan) – A complement inhibitor approved to reduce proteinuria in adults with IgA nephropathy who are at risk of rapid disease progression
• ACE inhibitors (angiotensin-converting enzyme inhibitors) – Medications that help lower blood pressure and reduce protein in the urine for people with kidney disease
• ARBs (angiotensin receptor blockers) – Medications that help lower blood pressure and reduce protein in the urine for people with kidney disease
• SGLT2 inhibitors (sodium-glucose transporter 2 inhibitors) – Medications that have demonstrated benefit in IgA nephropathy and have an established role in chronic kidney disease management